Tc(HSA17*P301L)1Mdk
Targeted Allele Detail
|
Symbol: |
Tc(HSA17*P301L)1Mdk |
Name: |
transchromosomal, human 17, line 2, Michael Koob; transchromosomal, human 17, line 1, Michael D Koob |
MGI ID: |
MGI:7284826 |
Synonyms: |
MAPT(H1.0*)P301L-GR |
Gene: |
Tc(HSA17*P301L)1Mdk Location: unknown Genetic Position: Chr11, Syntenic
|
Alliance: |
Tc(HSA17*P301L)1Mdk page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:101977
|
Parent Cell Line: |
PRX-B6N (ES Cell)
|
Strain of Origin: |
C57BL/6NTac
|
|
Allele Type: |
|
Targeted (Humanized sequence, Inserted expressed sequence) |
Mutations: |
|
Insertion, Intergenic deletion, Nucleotide substitutions
|
|
|
Tc(HSA17*P301L)1Mdk expresses
2 genes
Knock-in expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
MAPT (4137) |
|
|
human |
SPPL2C (162540) |
|
|
|
|
|
Mutation details: A 157 kb deletion on mouse chromosome 11 stretching from, but not including, Crhr1 to Kansl1 is replaced by a syntenic 190 kb region from human chromosome 17 (HSA17). In this transchromosomal (Tc) strain, the mouse Sppl2c (signal peptide peptidase 2C) and Mapt (microtubule-associated protein tau) genes are replaced by human SPPL2C and MAPT (H1 haplotype) genes. The human MAPT gene was modified to include the P301L (proline to leucine; CCG to CTG) mutation identified in FTDP-17 patients. The loxN-flanked neomycin resistance cassette that was removed by transient cre expression.
(J:101977)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
Carrying any Tc(HSA17*P301L)1Mdk Mutation: |
1 strain or line available
|
|
Original: |
J:101977 The Jackson Laboratory, Information obtained from The Jackson Laboratory, Bar Harbor, ME. Unpublished. 2005-2017; |
All: |
1 reference(s) |
|